Early Career Research(ECR) Award (R21 Clinical Trial Optional)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 15, 2026
Can you apply?
This grant is for early-career researchers investigating hearing, balance, taste, smell, or voice disorders. Applicants must have a doctoral degree (MD, PhD, DDS, DVM, or equivalent) and be within 5 years of their final degree or clinical training. U.S. citizens, nationals, and permanent residents are eligible. The research must be conducted at U.S. institutions. Both basic and clinical research projects are supported, including optional clinical trials. Preliminary data demonstrating feasibility is expected.
Non-profit organizations, universities, and research institutions can serve as fiscal sponsors. Government agencies may also be eligible depending on institutional policies. International collaboration is permitted if the lead investigator meets citizenship requirements.
This R21 mechanism supports exploratory research with innovation as a priority. Projects should be novel but may have limited preliminary data. The funding supports one five-year project period.
Not the right fit? Find grants for your organization in 5 questions →
Program description
The NIDCD Early Career Research (ECR) Award (R21) is intended to support both basic and clinical research from scientists who are beginning to establish an independent research career. It cannot be used for thesis or dissertation research. The research must be focused on one or more of the areas within the biomedical and behavioral scientific mission of the NIDCD: hearing, balance, smell, taste, voice, speech, or language. The NIDCD ECR Award R21 grant mechanism supports different types of projects including secondary analysis of existing data; small, self-contained research projects; development of research methodology; translational research; outcomes research; and development of new research technology. Irrespective of the type of project, the intent of the NIDCD ECR Award R21 is for the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) to obtain sufficient preliminary data for a subsequent R01 application.
Who can apply
Eligible applicants
How to apply
Application links
Required documents
- NIH R&R Application (SF424 R&R)
- Project Narrative
- Specific Aims (typically 1 page)
- Research Strategy
- Budget and Budget Justification
- Biosketches (investigator and key personnel)
- Supporting Letters (for collaboration and institutional support)
- Clinical trial protocol (if applicable)
- Previous Research Support documentation
Program contact
- 👤 National Institutes of Health
- 📧 grantsinfo@nih.gov
- 📞 301-402-2541
Funding track record
Recent awards under CFDA 93.173 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$67,501,043
-
$41,811,330
-
$29,666,573
-
$25,009,162
-
$22,883,624
-
$22,740,456
-
$16,596,227
-
$13,760,149
-
$12,363,350
-
$12,276,804
Top States by Funding
- MA 11 awards $143.1M
- CA 10 awards $101.6M
- IA 5 awards $77.5M
- CT 2 awards $76.3M
- MD 8 awards $65.0M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.173). How funding has trended year over year.
| 2024 | $422,034,489 | |
| 2025 | $422,700,014 | |
| 2026 est. | $427,030,000 |
FAQ
Who qualifies as an early-career researcher for this award?
You must have a research or clinical doctorate (MD, PhD, DDS, DVM, DO, or equivalent) and be within 5 years of your final degree. Clinical postdoctoral fellows and newly independent researchers are typical applicants. Prior NIH R01 funding may disqualify you.
What research topics are supported?
Projects on hearing loss, balance disorders, taste and smell dysfunction, and voice or speech disorders. Basic science, translational, and clinical research are all eligible. Clinical trials are optional but encouraged.
What are the funding amounts and project periods?
R21 awards typically fund exploratory research with moderate budgets. Project periods are usually 2 years. Check the most recent Notice of Funding Opportunity for exact dollar caps.
How competitive is this grant?
NIH R21 awards are moderately competitive. Success rates vary by institute but typically range from 15-25%. Strong innovation and feasibility data improve competitiveness.
What preliminary data is expected?
You should have some data showing your project is feasible. Preliminary data can be modest but should reduce perceived risk. Pilot studies are common for R21 applicants.
💡 Tips for applicants
- Frame your project as exploratory and innovative. R21s reward bold ideas with preliminary feasibility data, not comprehensive preliminary data.
- Clearly explain the clinical relevance to hearing, balance, taste, smell, or voice disorders. Connect your basic research to real patient outcomes.
- Develop a realistic, focused timeline. R21 projects should be well-scoped for 2 years with clear specific aims.
- Address scientific rigor and reproducibility. Include discussion of blinding, randomization, and sample size justification if applicable.
- Highlight early-career mentorship. Describe institutional support, collaborators, and career development plan to demonstrate capability.
⚠️ Common mistakes
Applications lacking clear innovation or preliminary feasibility data often fail. Overly ambitious scope that cannot be completed in the 2-year timeframe is a common reason for rejection. Weak connection between the proposed research and NIDCD's mission (hearing, balance, taste, smell, or voice disorders) undermines competitiveness.
Similar grants
- OPEN NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional) — National Institutes of Health
- OPEN Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) — National Institutes of Health
- CLOSING SOON Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) — National Institutes of Health
- OPEN NCMRR Early Career Research Award (R03 Clinical Trial Optional) — National Institutes of Health
- OPEN NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Not Allowed) — National Institutes of Health